Annie Philip
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Annie Philip has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Alexis Vangellow
Department of Anesthesiology & Perioperative Medicine, University of Rochester, Rochester, NY14642, USA
1 shared publicationAvinash Beeram
Department of Anesthesiology & Perioperative Medicine, University of Rochester, Rochester, NY14642, USA
1 shared publicationChangyong Feng
Department of Anesthesiology & Perioperative Medicine, University of Rochester, Rochester, NY14642, USA
1 shared publicationJenae Davis
Department of Anesthesiology & Perioperative Medicine, University of Rochester, Rochester, NY14642, USA
1 shared publicationJennifer Gewandter
Department of Anesthesiology & Perioperative Medicine, University of Rochester, Rochester, NY14642, USA
1 shared publicationJoseph Poli
Department of Anesthesiology & Perioperative Medicine, University of Rochester, Rochester, NY14642, USA
1 shared publication
Latest Publications
- 9 June 2021
- Published by Taylor & Francis in Pain Management
- Vol. 11 (6) , 669-677
Evaluating Predictors of Pain Reduction After Genicular Nerve Radiofrequency Ablation for Chronic Knee Pain
Aim: Radiofrequency ablation (RFA) of genicular nerves can treat refractory chronic knee pain. This study evaluated association between patient and procedural characteristics and pain improvement a... Lay abstract Aim: Using heat energy to stun the nerves (Radiofrequency ablation) that supply knee joint is a technique that can be used to decrease persistent knee pain. This study was performed to...
- 9 June 2021
- Published by Taylor & Francis in Pain Management
- Vol. 11 (6) , 669-677
Evaluating Predictors of Pain Reduction After Genicular Nerve Radiofrequency Ablation for Chronic Knee Pain
Aim: Radiofrequency ablation (RFA) of genicular nerves can treat refractory chronic knee pain. This study evaluated association between patient and procedural characteristics and pain improvement a... Lay abstract Aim: Using heat energy to stun the nerves (Radiofrequency ablation) that supply knee joint is a technique that can be used to decrease persistent knee pain. This study was performed to...
- 1 June 2011
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 14 (6) , 765-773
Post Herpetic Neuralgia
Background: During the past decade, important advances have been made in understanding the epidemiology, pathogenesis, prevention and treatment of Post herpetic neuralgia pain as well as treatment of other neuropathic pain conditions. PHN is accepted as a model for management and clinical trials of neuropathic pain of less clear etiologies. In palliative medicine, where the etiology of pain may be nociceptive, neuropathic, or mixed, it is frequently to the research on PHN that we turn in order to extrapolate the data to the patients at hand. Objective: To review and summarize what is known about epidemiology, pathogenesis, clinical features and prevention strategies for Post herpetic Neuralgia. Discuss the available including the most recent therapeutic options as regards to their mechanism of action, efficacy, safety and tolerability in an attempt to explain the rationale for their use. Conclusion: A multidisciplinary and integrative approach has the best chance of success in the management of patients with PHN pain, a problem that can be often frustrating to the patient and challenging to the clinician. Prevention strategies for PHN include administration of zoster vaccine, treatment with antiviral therapy within 72 hours of rash onset and aggressive pain control. First and second line pharmacotherapy include anticonvulsants, antidepressants, topical lidocaine, high dose capsaicin, and opioids either used individually or in combination. Interventional techniques play a limited role in the management of PHN although some data indicate that Intrathecal methylprednisolone and spinal cord stimulation may be effective.
- 1 June 2011
- Published by SAGE Publications in Journal of Palliative Medicine
- Vol. 14 (6) , 765-773
Post Herpetic Neuralgia
Background: During the past decade, important advances have been made in understanding the epidemiology, pathogenesis, prevention and treatment of Post herpetic neuralgia pain as well as treatment of other neuropathic pain conditions. PHN is accepted as a model for management and clinical trials of neuropathic pain of less clear etiologies. In palliative medicine, where the etiology of pain may be nociceptive, neuropathic, or mixed, it is frequently to the research on PHN that we turn in order to extrapolate the data to the patients at hand. Objective: To review and summarize what is known about epidemiology, pathogenesis, clinical features and prevention strategies for Post herpetic Neuralgia. Discuss the available including the most recent therapeutic options as regards to their mechanism of action, efficacy, safety and tolerability in an attempt to explain the rationale for their use. Conclusion: A multidisciplinary and integrative approach has the best chance of success in the management of patients with PHN pain, a problem that can be often frustrating to the patient and challenging to the clinician. Prevention strategies for PHN include administration of zoster vaccine, treatment with antiviral therapy within 72 hours of rash onset and aggressive pain control. First and second line pharmacotherapy include anticonvulsants, antidepressants, topical lidocaine, high dose capsaicin, and opioids either used individually or in combination. Interventional techniques play a limited role in the management of PHN although some data indicate that Intrathecal methylprednisolone and spinal cord stimulation may be effective.